Abstracts
A Multicenter, Placebo-Controlled, Phase 3 Study of Etripamil in Patients with Atrial Fibrillation and Rapid Ventricular Rate: ReVeRA-301 Trial Design
Current Issue
April 2026
Volume 26
Issue 4
Stay in the know.
EP Lab Digest Newsletter
